Development of novel tumour-activated peptide prodrugs of ATR/ATM inhibitor, AZD6738

Barnieh, Francis M.

dc.contributor.advisor	Falconer, Robert A.
dc.contributor.advisor	Loadman, Paul M.
dc.contributor.author	Barnieh, Francis M.
dc.date.accessioned	2022-08-04T15:33:30Z
dc.date.available	2022-08-04T15:33:30Z
dc.date.issued	2019
dc.identifier.uri	http://hdl.handle.net/10454/19091
dc.language.iso	en	en_US
dc.rights	<a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><img alt="Creative Commons License" style="border-width:0" src="http://i.creativecommons.org/l/by-nc-nd/3.0/88x31.png" /></a><br />The University of Bradford theses are licenced under a <a rel="license" href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Licence</a>.	eng
dc.subject	Prodrug	en_US
dc.subject	Peptide	en_US
dc.subject	Tumour	en_US
dc.subject	ATM	en_US
dc.subject	ATR	en_US
dc.subject	AZD6738	en_US
dc.subject	Tumour-activated peptide prodrugs	en_US
dc.subject	Cancer	en_US
dc.title	Development of novel tumour-activated peptide prodrugs of ATR/ATM inhibitor, AZD6738	en_US
dc.type.qualificationlevel	doctoral	en_US
dc.publisher.institution	University of Bradford	eng
dc.publisher.department	Faculty of Life Sciences	en_US
dc.type	Thesis	eng
dc.type.qualificationname	PhD	en_US
dc.date.EndofEmbargo	2025-04-03
dc.date.awarded	2019
dc.description.publicnotes	The full text will be available at the end of the embargo period: 3rd April 2025	en
dc.description.publicnotes	The author's name as given on this thesis is Francis MPRAH BARNIEH. His publications use the name format Francis M. Barnieh.	en